Questran Lite colestyramine powder

Questran Lite is a prescription medication containing colestyramine, primarily used to lower cholesterol levels and treat certain types of itching associated with liver disease. The brand has a long history in the pharmaceutical industry, originally developed by Bristol-Myers Squibb (BMS) in the United States. It has been a standard treatment for bile acid sequestration for several decades.

Today, the brand is owned and distributed globally by Viatris, a healthcare company formed in 2020 through the merger of Mylan and Pfizer's Upjohn division. While the brand originated in the US, manufacturing for global markets such as Australia (as indicated by the AUST R number on the packaging) and Europe occurs in various specialized pharmaceutical facilities internationally to meet local regulatory and supply requirements. The ultimate ownership resides with Viatris Inc., a major American pharmaceutical corporation headquartered in Pennsylvania.